SPC
JNJ icon

Salient Private Client’s Johnson & Johnson JNJ Stock Holding History

Salient Private Client’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$11.7M Sell
84,971
-937
-1% -$125K 2.29% 7
2018
Q2 		$10.4M Sell
85,908
-8,826
-9% -$1.1M 1.75% 11
2018
Q1 		$12.1M Buy
94,734
+10,602
+13% +$1.43M 2.13% 10
2017
Q4 		$11.8M Buy
+84,132
New +$11.7M 2.41% 8

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Salient Private Client's JNJ Position: Q3 2018 in Review

Salient Private Client reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q3 2018, selling an estimated $125K and leaving 84,971 shares worth $11.7M. The position accounts for 2.29% of the portfolio, ranked #7.

Salient Private Client first reported a position in JNJ in Q4 2017 and has held it in 4 quarters since. The position peaked at $12.1M in Q1 2018. 2,583 funds tracked by Wall St. Rank hold JNJ as of Q3 2018.

  • Salient Private Client held 84,971 shares of Johnson & Johnson worth $11.7M as of Q3 2018.
  • Salient Private Client sold 937 Johnson & Johnson shares in Q3 2018, an estimated $125K.
  • Johnson & Johnson made up 2.29% of Salient Private Client's portfolio in Q3 2018, its #7 holding.
  • Salient Private Client first reported a position in Johnson & Johnson in Q4 2017 and has held it in 4 quarters since.
  • Salient Private Client's Johnson & Johnson position peaked at $12.1M in Q1 2018.
  • 2,583 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2018.

Based on Salient Private Client's 13F filing for Q3 2018, filed 14 Nov 2018.